Equities

Recordati Industria Chimica e Farmaceutica SpA

Recordati Industria Chimica e Farmaceutica SpA

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (EUR)50.60
  • Today's Change-1.26 / -2.43%
  • Shares traded679.07k
  • 1 Year change+13.12%
  • Beta0.1523
Data delayed at least 15 minutes, as of Sep 17 2021 16:35 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.
More ▼

Key statistics

On Friday, Recordati Industria Chimica e Farmaceutica SpA (REC:MIL) closed at 50.60, -12.61% below its 52-week high of 57.90, set on Aug 23, 2021.
52-week range
Today
41.02Jan 29 202157.90Aug 23 2021
Markit short selling activity
Low
Med
High
Open51.64
High51.82
Low50.54
Bid50.52
Offer51.70
Previous close50.60
Average volume244.16k
Shares outstanding209.13m
Free float100.76m
P/E (TTM)28.98
Market cap10.58bn EUR
EPS (TTM)1.75
EUR
Annual div (ADY)1.05
EUR
Annual div yield (ADY)2.08%
Div ex-dateMay 24 2021
Div pay-dateMay 26 2021
Data delayed at least 15 minutes, as of Sep 17 2021 16:35 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.
image